From fiction to science: clinical potentials and regulatory considerations of gene editing
Abstract Gene editing technologies such as CRISPR/Cas9 have emerged as an attractive tool not only for scientific research but also for the development of medicinal products. Their ability to induce precise double strand breaks into DNA enables targeted modifications of the genome including selectiv...
Main Authors: | Maria Schacker, Diane Seimetz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-019-0244-7 |
Similar Items
-
Understanding the Potential of Genome Editing in Parkinson’s Disease
by: David Arango, et al.
Published: (2021-08-01) -
The Ethics of Gene Modification: Considerations of Gene Editing and Genetic Selection
by: Murwani Emasrissa Latifah
Published: (2021-02-01) -
MALBoost: a web-based application for gene regulatory network analysis in Plasmodium falciparum
by: Roelof van Wyk, et al.
Published: (2021-07-01) -
Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research
by: Marc Kusinitz, et al.
Published: (2017-06-01) -
Regulatory RNA Editing Sites in Cancer: Prediction and Beyond
by: Hang Ruan, et al.
Published: (2018-01-01)